ReviewAnnals of hematology2025
Adapting haematology practices for effective management of blood disorders in pregnancy in a limited resource setting.
Review in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal-Fetal Risks, and Management Strategies.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHaematology plays a crucial role in the management of pregnant females as blood disorders are common in these patients which can significantly impact on maternal and fetal health. This paper explores how haematology can adapt its practice to address the unique challenges posed by physiological/pathological changes during pregnancy.
methodsA comprehensive review of the physiological changes in blood volume, coagulation, and haematological parameters during pregnancy was conducted. Case series of pregnant women with various blood disorders, including gestational thrombocytopenia, iron deficiency anaemia, venous thromboembolism, sickle cell disease, and thalassemia, were analysed to illustrate management strategies.
resultsThe physiological increase in blood volume during pregnancy leads to dilutional effects on haematological parameters, complicating diagnosis and management. Conditions such as gestational thrombocytopenia and anaemia require tailored approaches, while the increased risk of thromboembolic events necessitates proactive risk assessment and prophylactic measures. The management of pre-existing blood disorders demands a multidisciplinary approach, emphasizing collaboration between haematologists and obstetricians. DISCUSSION: Effective management of blood disorders in pregnancy is essential on understanding physiological changes, individualized care plans, and patient education. Empowering patients with knowledge about their conditions and potential complications is essential for optimizing outcomes.
conclusionAdapting haematology practice for pregnancy management is vital for addressing the complexities of blood disorders during the critical pregnancy period. A multidisciplinary approach, ongoing education, and research advancements are essential for improving maternal and fetal health outcomes. By fostering collaboration across specialties, healthcare providers can work towards achieving the best possible outcomes for pregnant woman with haematological conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.